Amyloid beta enhances cytosolic phospholipase A2 level and arachidonic acid release via nitric oxide in APP-transfected PC12 cells

Acta Biochimica Polonica

Volumn 54, Issue 3, 2007, Pages 611-623

  Chalimoniuk, Małgorzata ^a   Stolecka, Anna ^a,b   Ca̧kała, Magdalena ^a   Hauptmann, Susane ^c   Schulz, Kris ^c   Lipka, Uta ^c   Leuner, Kristine ^c   Eckert, Anne ^d   Muller, Walter E ^c   Strosznajder, Joanna B ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b INSTITUTE OF SPORT SCIENCES   (Poland)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Amyloid beta; Antioxidative enzymes; Arachidonic acid; Calcium; Cytosolic phospholipase A2; Mitochondria; Nitric oxide synthase; Reactive oxygen species

Indexed keywords

RATTUS;

EID: 35348922283     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2007_3235     Document Type: Article

References (55)

1. Adamczyk A, Kazimierczak A, Strosznajder JB (2006) Alpha-synuclein and its neurotoxic fragment inhibit dopamine uptake into rat striatal synaptosomes. Relationship to nitric oxide. Neurochem Int 49: 407-412.
2. Bazan NG, Colangelo V, Lukiw WJ (2002) Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins Other Lipid Mediat 68-69: 197-210.
3. 2+-independent phospholipase A2 in uterine stromal cells. Biochem Biophys Res Commun 276: 613-618.
4. Buchet R, Pikuła S (2000) Alzheimer's disease: its origin at the membrane, evidence and questions. Acta Biochim Polon 47: 725-733.
5. Butterfield DA (2002) Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res 36: 1307-1313.
6. Butterfield DA, Boyd-Kimball D (2004) Amyloid beta-peptide (1-42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain. Brain Pathol 14: 426-432.
7. Cai XD, Golde TE, Younkin SG (1993) Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science 259: 514-516.
8. Chalimoniuk M, Strosznajder JB (1998) Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Effects of amyloid beta peptide. Mol Chem Neuropathol 35: 77-95.
9. Chalimoniuk M, Głowacka J, Zabielna A, Eckert A, Strosznajder JB (2006a) Nitric oxide alters arachidonic acid turnover in brain cortex synaptoneurosomes. Neurochem Int 48: 1-8.
10. Chalimoniuk M, King-Pospisil K, Metz CN, Toborek M (2006b) Macrophage migration inhibitor factor induces cell death and decreases neuronal nitric oxide expression in spinal cord neurons. Neuroscience 139: 1117-1128.
11. Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, Johnsin-Wood R, Lee M, Seubert P, Davis A, Kholodenko D, Motter R, Sherrington R, Perry B, Yao H, Stome R, Lieberburg I, Rommens J, Kim S, Schenk D, Fraser P, St George-Hyslop P, Selkoe DJ (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta transfected cells and transgenic mice. Nat Med 3: 1021-1023.
12. Dobashi K, Asayama K, Nakane T, Kodera K, Hayashibe H, Nakazawa S (2001) Induction of glutathione peroxidase in response to inactivation by nitric oxide. Free Radic Res 35: 319-327.
13. Eckert A, Steiner B, Marques C, Leutz S, Romig H, Haass C, Muller WE (2001) Elevated vulnerability to oxidative stress-induced cell death and activation of caspase-3 by the Swedish amyloid precursor protein mutation. J Neurosci Res 64: 183-193.
14. 2 phosphorylation and translocation. BMC Biochem 3: 30-42.
15. 2 and its role in brain tissue. J Neurochem 69: 889-901.
16. 2 regulation. J Biol Chem 275: 20146-20156.
17. Haass C (2004) Take five-BACE and the gamma-secretase quartet conduct Alzheimer's amyloid β-peptide generation. EMBO J 23: 483-488.
18. 2 via a Gqα-dependent ERK-independent pathway. J Biol Chem 276: 13941-13948.
19. Hauptmann S, Keil U, Scherping I, Bonert A, Eckert A, Muller WE (2006) Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease. Exp Gerontol 41: 668-673.
20. Hempel SL, Buettner GR, O'Malley YQ, Wessels DA, Flaherty DM (1999) Dihydrofluorescein diacetate is superior for detecting intracellular oxidants: comparison with 2′,7′-dichlorodihydrofluorescein diacetate, 5 (and 6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate, and dihydrorhodamine 123. Free Radic Biol Med 27: 146-159.
21. Holscher C (1998) Possible causes of Alzheimer's disease: amyloid fragments, free radicals, and calcium homeostasis. Neurobiol Dis 5: 129-141.
22. Keil U, Bonert A, Marques CA, Scherping I, Weyermann J, Strosznajder JB, Muller-Spahn F, Haass Ch, Czech Ch, Paradier L, Muller WE, Eckert A (2004) Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis. J Biol Chem 279: 50310-50320.
23. Kukreja RC, Kontos HA, Hess ML, Ellis E (1986) PGH synthase and lipooxygenase generate superoxide in the presence of NADH or NADPH. Circul Res 59: 612-619, 1986.
24. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
25. Lahiri DK, Chen D, Ge Y-W, Farlow M, Kotwal G, Kanthasamy A, Ingram DK, Greig NH (2003) Does nitric oxide synthase contribute to the pathogenesis of Alzheimer's disease? Effects of β-amyloid deposition on NOS in transgenic mouse brain with AD pathology. Ann NY Acad Sci 1010: 639-642.
26. Lukiw WJ, Bazan NG (2000) Neuroinflammatory signaling upregulation in Alzheimer's disease. Neurochem Res 25: 1173-1184.
27. Luth HJ, Arendt Th (1998) Nitric oxide and Alzheimer's disease. J Brain Res 39: 245-251.
28. Luth HJ, Holzer M, Gartner U, Staufenbiel M, Arendt T (2001) Expression of endothelial and inducible NOSisoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology. Brain Res 913: 57-67.
29. 2 by superoxide. Arch Biochem Biophys 346: 187-192.
30. Marques CA, Keil U, Bonert A, Steiner B, Haass C, Muller WE, Eckert A (2003) Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway. J Biol Chem 278: 28294-28302.
31. Miyamoto Y, Koh YH, Park YS, Fujiwara N, Sakiyama H, Misonou Y, Ookawara T, Suzuki K, Honke K, Taniguchi N (2003) Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses. J Biol Chem 384: 567-574.
32. 2 are expressed in rat brain. Neurosci Lett 258: 139-142.
33. 2. Crit Rev Immunol 17: 225-283.
34. 2 in PC12 cells. J Neurochem 75: 2445-2454.
35. Perry G, Cash AD, Smith MA (2002) Alzheimer's disease and oxidative stress. J Biomed Biotechnol 2: 120-123.
36. Pratico D, Sung S (2004) Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J Alzheimers Dis 6: 171-175.
37. Rosenberger TA, Villacreses NE, Hovda JT, Bosetti F, Weerasinghe G, Wine RN, Harry GJ, Rapoport SI (2004) Rat brain arachidonic acid metabolism is induced by a six-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J Neurochem 88: 1168-1178.
38. 2 activity. J Neurochem 70: 786-793.
39. Rothe G, Valet G (1990) Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′,7′- dichlorofluorescin. J Leukocyt Biol 47: 440-448.
40. 2 in cultured endothelial cells. Arch Biochem Biophys 302: 348-355.
41. Samanta S, Perkinton MS, Morgan M, Williams RJ (1998) Hydrogen peroxide enhances signal-responsive arachidonic acid release from neurons: role of mitogen-activated protein kinase. J Neurochem 70: 2082-2090.
42. 2, potentiates hydrogen peroxide cytotoxicity in kidney epithelial cells. J Biol Chem 271: 21505-21513.
43. Schuessel K, Frey C, Jourdan C, Keil U, Weber CC, Muller-Spahn F, Muller WE, Eckert A, (2006) Aging sensitizes toward ROS formation and lipid peroxidation in PS1M146L transgenic mice. Free Radic Biol Med 40: 850-862.
44. Selkoe DJ (2001) Presenilin, Notch, and the genesis and treatment of Alzheimer's disease. Proc Natl Acad Sci USA 98: 11039-11041.
45. Selkoe DJ (2006) The ups and downs of Aβ. Nature Med 12: 758-759.
46. Shasby DM, Winter M, Shasby SS (1988) Oxidants and conductance of cultured epithelial cell monolayers: inositol phospholipid hydrolysis. Am J Physiol 255: C781-C788.
47. 2+ ionophores, but not to tumor necrosis factor-alpha. J Pharm Sci 96: 324-332.
48. 2 enzymes: classification and characterization. Biochim Biophys Acta 1488: 1-19.
49. 2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol Dis 3: 51-63.
50. 2+. Br J Pharmacol 139: 1014-1022.
51. 2 in the central nervous system: implications for neurodegenerative diseases. J Lipids Res 45: 205-213.
52. Teismann P, Vila M, Choi DK, Tieu K, Wu DC, Jackson-Lewis V, Przedborski S (2003) COX-2 and neurodegeneration in Parkinson's disease. Ann N Y Acad Sci 991: 272-277.
53. 2 phosphorylation and arachidonic acid release in primary murine astrocytes. J Neurochem 83: 259-270.
54. 2. Free Radic Biol Med 34: 1531-1543.
55. Yatin SM, Varadarajan S, Link CD, Butterfield DA (1999) In vitro and in vivo oxidative stress associated with Alzheimer's amyloid-beta peptide (1-42). Neurobiol Aging 20: 325-330; Discussion 339-342.